Annual EBIT
-$38.26 M
+$2.04 M+5.06%
31 December 2022
Summary:
Better Therapeutics annual earnings before interest & taxes is currently -$38.26 million, with the most recent change of +$2.04 million (+5.06%) on 31 December 2022. During the last 3 years, it has fallen by -$32.13 million (-523.77%). BTTX annual EBIT is now -562.77% below its all-time high of -$5.70 million.BTTX EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBIT
-$5.34 M
+$1.68 M+23.97%
30 September 2023
Summary:
Better Therapeutics quarterly earnings before interest & taxes is currently -$5.34 million, with the most recent change of +$1.68 million (+23.97%) on 30 September 2023. BTTX quarterly EBIT is now -426.21% below its all-time high of -$1.01 million, reached on 30 June 2020.BTTX Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBIT
-$29.61 M
+$5.66 M+16.03%
30 September 2023
Summary:
Better Therapeutics TTM earnings before interest & taxes is currently -$29.61 million, with the most recent change of +$5.66 million (+16.03%) on 30 September 2023. BTTX TTM EBIT is now -2817.54% below its all-time high of -$1.01 million, reached on 30 June 2020.BTTX TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BTTX EBIT Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | - | - | - |
3 y3 years | -523.8% | +57.1% | -11.4% |
5 y5 years | - | - | - |
BTTX EBIT High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3 years | -523.8% | +5.1% | at high | +61.1% | -11.4% | +34.4% |
5 y | 5 years | -562.8% | +5.1% | -426.2% | +61.1% | -2817.5% | +34.4% |
alltime | all time | -562.8% | +5.1% | -426.2% | +61.1% | -2817.5% | +34.4% |
Better Therapeutics EBIT History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sept 2023 | - | -$5.34 M(-24.0%) | -$29.61 M(-16.0%) |
June 2023 | - | -$7.03 M(-21.3%) | -$35.27 M(-6.8%) |
Mar 2023 | - | -$8.93 M(+7.2%) | -$37.84 M(-1.1%) |
Dec 2022 | -$38.26 M(-5.1%) | -$8.32 M(-24.3%) | -$38.26 M(-12.4%) |
Sept 2022 | - | -$11.00 M(+14.6%) | -$43.66 M(-3.2%) |
June 2022 | - | -$9.60 M(+2.7%) | -$45.12 M(+2.2%) |
Mar 2022 | - | -$9.35 M(-31.9%) | -$44.17 M(+9.6%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Dec 2021 | -$40.30 M(+557.0%) | -$13.71 M(+10.1%) | -$40.30 M(+51.6%) |
Sept 2021 | - | -$12.46 M(+44.1%) | -$26.59 M(+88.2%) |
June 2021 | - | -$8.65 M(+57.8%) | -$14.13 M(+117.5%) |
Mar 2021 | - | -$5.48 M(+439.8%) | -$6.49 M(+539.8%) |
Dec 2020 | -$6.13 M(+6.3%) | - | - |
June 2020 | - | -$1.01 M | -$1.01 M |
Dec 2019 | -$5.77 M | - | - |
FAQ
- What is Better Therapeutics annual earnings before interest & taxes?
- What is the all time high annual EBIT for Better Therapeutics?
- What is Better Therapeutics quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Better Therapeutics?
- What is Better Therapeutics TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Better Therapeutics?
What is Better Therapeutics annual earnings before interest & taxes?
The current annual EBIT of BTTX is -$38.26 M
What is the all time high annual EBIT for Better Therapeutics?
Better Therapeutics all-time high annual earnings before interest & taxes is -$5.70 M
What is Better Therapeutics quarterly earnings before interest & taxes?
The current quarterly EBIT of BTTX is -$5.34 M
What is the all time high quarterly EBIT for Better Therapeutics?
Better Therapeutics all-time high quarterly earnings before interest & taxes is -$1.01 M
What is Better Therapeutics TTM earnings before interest & taxes?
The current TTM EBIT of BTTX is -$29.61 M
What is the all time high TTM EBIT for Better Therapeutics?
Better Therapeutics all-time high TTM earnings before interest & taxes is -$1.01 M